NCT03770702View on ClinicalTrials.gov

Statins and ARBs on Rheumatoid Activity

PHASE3RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Angiotensin receptor blockers

Candesartan

DRUG

Statins

Atorvastatin

Trial Locations (1)

35111

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Sherief Abd-Elsalam

OTHER

NCT03770702 - Statins and ARBs on Rheumatoid Activity | Biotech Hunter | Biotech Hunter